GlobalData on MSN3mon
Daiichi Sankyo doses first subject in Phase III AML therapy trial
Daiichi Sankyo has announced the dosage of the first subject in the randomised Phase III QuANTUM-Wild trial of oral Vanflyta ...
Using machine learning tools to detect gene mutations from leukemia cell images
The AI was trained and tested using real medical images, and the results showed that it can predict mutations in genes like NPM1 and FLT3-ITD with promising accuracy. This means that in the future, AI ...